Status:
COMPLETED
Study of Tolerance to Oral Peanut
Lead Sponsor:
Cambridge University Hospitals NHS Foundation Trust
Conditions:
Peanut Allergy
Eligibility:
All Genders
7-17 years
Phase:
PHASE1
Brief Summary
Open pilot study of peanut oral immunotherapy in 22 children with peanut allergy
Detailed Description
Background Peanut allergy is severe and rarely resolves. Objective To test the efficacy and safety of a new oral immunotherapy protocol for peanut allergy. Method 22 peanut-allergic children will un...
Eligibility Criteria
Inclusion
- Peanut allergy defined by oral challenge
Exclusion
- Major immunodeficiency
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2012
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT01259804
Start Date
January 1 2008
End Date
January 1 2012
Last Update
January 14 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cambridge Biomedical Campus
Cambridge, Cambridgeshire, United Kingdom, CB23 7DS